vs

Side-by-side financial comparison of KKR Real Estate Finance Trust Inc. (KREF) and OptimizeRx Corp (OPRX). Click either name above to swap in a different company.

OptimizeRx Corp is the larger business by last-quarter revenue ($32.2M vs $25.8M, roughly 1.2× KKR Real Estate Finance Trust Inc.). OptimizeRx Corp runs the higher net margin — 15.6% vs -101.7%, a 117.3% gap on every dollar of revenue. On growth, OptimizeRx Corp posted the faster year-over-year revenue change (-0.2% vs -26.6%). Over the past eight quarters, OptimizeRx Corp's revenue compounded faster (28.0% CAGR vs -18.8%).

KKR Real Estate Finance Trust Inc. is a specialized real estate finance firm sponsored by global investment firm KKR. It primarily originates, acquires, and manages a portfolio of senior secured commercial real estate loans, mostly backed by high-quality institutional commercial properties across the United States, delivering stable risk-adjusted returns to investors via interest income from its diversified assets.

OptimizeRx Corp is a U.S.-headquartered digital health technology company that delivers patient engagement, medication affordability and clinical communication solutions to life sciences enterprises, healthcare providers and pharmacy partners. Its core offerings include digital medication savings tools, patient support programs, and therapeutic area-specific resources to boost medication access and treatment adherence.

KREF vs OPRX — Head-to-Head

Bigger by revenue
OPRX
OPRX
1.2× larger
OPRX
$32.2M
$25.8M
KREF
Growing faster (revenue YoY)
OPRX
OPRX
+26.4% gap
OPRX
-0.2%
-26.6%
KREF
Higher net margin
OPRX
OPRX
117.3% more per $
OPRX
15.6%
-101.7%
KREF
Faster 2-yr revenue CAGR
OPRX
OPRX
Annualised
OPRX
28.0%
-18.8%
KREF

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KREF
KREF
OPRX
OPRX
Revenue
$25.8M
$32.2M
Net Profit
$-26.2M
$5.0M
Gross Margin
74.8%
Operating Margin
-105.1%
26.6%
Net Margin
-101.7%
15.6%
Revenue YoY
-26.6%
-0.2%
Net Profit YoY
-229.6%
6535.9%
EPS (diluted)
$-0.49
$0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KREF
KREF
OPRX
OPRX
Q4 25
$25.8M
$32.2M
Q3 25
$25.3M
$26.1M
Q2 25
$30.2M
$29.2M
Q1 25
$31.3M
$21.9M
Q4 24
$35.1M
$32.3M
Q3 24
$37.0M
$21.3M
Q2 24
$40.4M
$18.8M
Q1 24
$39.1M
$19.7M
Net Profit
KREF
KREF
OPRX
OPRX
Q4 25
$-26.2M
$5.0M
Q3 25
$13.8M
$779.0K
Q2 25
$-29.7M
$1.5M
Q1 25
$-4.9M
$-2.2M
Q4 24
$20.3M
$-78.0K
Q3 24
$-7.4M
$-9.1M
Q2 24
$25.8M
$-4.0M
Q1 24
$-3.1M
$-6.9M
Gross Margin
KREF
KREF
OPRX
OPRX
Q4 25
74.8%
Q3 25
67.2%
Q2 25
63.8%
Q1 25
60.9%
Q4 24
68.1%
Q3 24
63.1%
Q2 24
62.2%
Q1 24
62.0%
Operating Margin
KREF
KREF
OPRX
OPRX
Q4 25
-105.1%
26.6%
Q3 25
50.4%
7.9%
Q2 25
-101.3%
10.9%
Q1 25
-18.3%
-9.6%
Q4 24
55.8%
11.2%
Q3 24
-19.6%
-40.2%
Q2 24
63.3%
-19.9%
Q1 24
-8.7%
-25.5%
Net Margin
KREF
KREF
OPRX
OPRX
Q4 25
-101.7%
15.6%
Q3 25
54.4%
3.0%
Q2 25
-98.5%
5.2%
Q1 25
-15.5%
-10.0%
Q4 24
57.7%
-0.2%
Q3 24
-20.0%
-42.8%
Q2 24
63.9%
-21.3%
Q1 24
-7.9%
-35.0%
EPS (diluted)
KREF
KREF
OPRX
OPRX
Q4 25
$-0.49
$0.27
Q3 25
$0.12
$0.04
Q2 25
$-0.53
$0.08
Q1 25
$-0.15
$-0.12
Q4 24
$0.22
$0.00
Q3 24
$-0.19
$-0.50
Q2 24
$0.29
$-0.22
Q1 24
$-0.13
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KREF
KREF
OPRX
OPRX
Cash + ST InvestmentsLiquidity on hand
$84.6M
$23.4M
Total DebtLower is stronger
$26.3M
Stockholders' EquityBook value
$1.2B
$128.3M
Total Assets
$6.5B
$176.9M
Debt / EquityLower = less leverage
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KREF
KREF
OPRX
OPRX
Q4 25
$84.6M
$23.4M
Q3 25
$204.1M
$19.5M
Q2 25
$107.7M
$16.6M
Q1 25
$106.4M
$16.6M
Q4 24
$104.9M
$13.4M
Q3 24
$108.8M
$16.1M
Q2 24
$107.2M
Q1 24
$106.5M
Total Debt
KREF
KREF
OPRX
OPRX
Q4 25
$26.3M
Q3 25
$28.8M
Q2 25
$29.3M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$36.8M
Q2 24
$37.3M
Q1 24
$37.8M
Stockholders' Equity
KREF
KREF
OPRX
OPRX
Q4 25
$1.2B
$128.3M
Q3 25
$1.2B
$122.3M
Q2 25
$1.2B
$119.3M
Q1 25
$1.3B
$116.3M
Q4 24
$1.3B
$117.0M
Q3 24
$1.4B
$114.5M
Q2 24
$1.4B
$121.0M
Q1 24
$1.4B
$122.5M
Total Assets
KREF
KREF
OPRX
OPRX
Q4 25
$6.5B
$176.9M
Q3 25
$6.5B
$170.3M
Q2 25
$6.8B
$169.3M
Q1 25
$6.6B
$167.8M
Q4 24
$6.4B
$171.2M
Q3 24
$6.8B
$165.2M
Q2 24
$7.1B
$172.9M
Q1 24
$7.3B
$176.4M
Debt / Equity
KREF
KREF
OPRX
OPRX
Q4 25
0.20×
Q3 25
0.24×
Q2 25
0.25×
Q1 25
0.29×
Q4 24
0.29×
Q3 24
0.32×
Q2 24
0.31×
Q1 24
0.31×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KREF
KREF
OPRX
OPRX
Operating Cash FlowLast quarter
$72.3M
$7.1M
Free Cash FlowOCF − Capex
$7.1M
FCF MarginFCF / Revenue
22.0%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.41×
TTM Free Cash FlowTrailing 4 quarters
$18.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KREF
KREF
OPRX
OPRX
Q4 25
$72.3M
$7.1M
Q3 25
$18.5M
$3.2M
Q2 25
$21.1M
$4.6M
Q1 25
$15.9M
$3.9M
Q4 24
$132.6M
$198.0K
Q3 24
$49.1M
$1.8M
Q2 24
$30.6M
$782.0K
Q1 24
$34.5M
$2.1M
Free Cash Flow
KREF
KREF
OPRX
OPRX
Q4 25
$7.1M
Q3 25
$3.2M
Q2 25
$4.6M
Q1 25
$3.8M
Q4 24
$181.0K
Q3 24
$1.8M
Q2 24
$737.0K
Q1 24
$2.1M
FCF Margin
KREF
KREF
OPRX
OPRX
Q4 25
22.0%
Q3 25
12.2%
Q2 25
15.6%
Q1 25
17.5%
Q4 24
0.6%
Q3 24
8.3%
Q2 24
3.9%
Q1 24
10.6%
Capex Intensity
KREF
KREF
OPRX
OPRX
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.1%
Q2 24
0.2%
Q1 24
0.2%
Cash Conversion
KREF
KREF
OPRX
OPRX
Q4 25
1.41×
Q3 25
1.34×
4.11×
Q2 25
2.98×
Q1 25
Q4 24
6.54×
Q3 24
Q2 24
1.19×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons